1. Home
  2. Documents

HIV Drug Resistance Documents

Date Range
Guidance for Developing Status Profiles on Communicable Diseases to Further Progress toward Their Elimination in the Region of the Americas
Guidance for Developing Status Profiles on Communicable Diseases to Further Progress toward Their Elimination in the Region of the Americas
Field guides
Sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy
Sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy
Technical and scientific products
HIV drug resistance report 2021
HIV drug resistance report 2021
Technical reports
Clinic-based survey of acquired HIV drug resistance
Clinic-based survey of acquired HIV drug resistance
Technical and scientific products
HIV drug resistance strategy, 2021 update
HIV drug resistance strategy, 2021 update
Mandates and Strategies
Laboratory-based survey of acquired HIV drug resistance using remnant viral load specimens
Laboratory-based survey of acquired HIV drug resistance using remnant viral load specimens
Technical and scientific products
HIV drug resistance surveillance in countries scaling up pre-exposure prophylaxis
HIV drug resistance surveillance in countries scaling up pre-exposure prophylaxis
Guidelines
WHO HIVResNet HIV drug resistance laboratory operational framework
WHO HIVResNet HIV drug resistance laboratory operational framework
Mandates and Strategies
cover
Consolidated HIV strategic information guidelines: driving impact through programme monitoring and management; 2020
Technical and scientific products
cover
Policy brief. Update of recommendations on first- and second-line antiretroviral regimens; July 2019
Technical and scientific products
cover
HIV drug resistance report 2019 (Sólo en inglés)
Technical and scientific products
cover
Guidelines on the public health response to pretreatment HIV drug resistance: July 2017
Technical and scientific products
cover
Global Action Plan on HIV Drug Resistance 2017–2021. Progress report
Mandates and Strategies
cover
Tackling HIV drug resistance: trends, guidelines and global action; 2017
Mandates and Strategies
cover
Surveillance of HIV drug resistance in children newly diagnosed with HIV by early infant diagnosis. Concept note; 2017
Technical and scientific products
Global action plan on HIV drug resistance 2017–2021
Global action plan on HIV drug resistance 2017–2021
Mandates and Strategies
cover
Consolidated guidelines on person centred hiv patient monitoring and case surveillance. Annex 2.4.6 HIVDR EWI sampling, abstraction and reporting guidance; 2017 (sólo en inglés)
Technical and scientific products
cover
WHO/HIVResNet HIV drug resistance laboratory operational framework (Sólo en inglés)
Mandates and Strategies
cover
HIV drug resistance report 2017 (sólo en inglés)
Technical and scientific products
Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta- Analysis; 2016 (Sólo en inglés)
Technical and scientific products
cover
Global report on early warning indicators of HIV drug resistance; 2016 (sólo en inglés)
Technical and scientific products